SS18 Antibody

1. Thirty-four patients (20 males and 14 females, mean of 31years) with SS18-SSX fusion-positive SS-HN were identified. The parapharyngeal region of the neck was the most common site PMID: 28249647
2. Kidney transplant recipients' polymorphisms of genes associated with telomere length, BICD1 and chromosome 18, but not hTERT, affect kidney allograft early and long-term function after transplantation. PMID: 27496426
3. Case Report: bronchial biphasic synovial sarcoma with SS18 gene rearrangement. PMID: 24429587
4. SYT gene split is associated with Synovial sarcoma. PMID: 24922679
5. SS18-SSX fusion type is a significant prognostic factor for patients with synovial sarcoma. PMID: 24022186
6. Studies show that in the 2 synovial sarcoma cell lines used, the fusion of SS18 with SSX leads to assembly of aberrant BAF complexes that become targeted to the Sox2 locus, with loss of repressive H3K27me3 marks, driving Sox2 expression and proliferation of these cells. PMID: 23540691
7. SYT-SSX2 was recruited to distinct loci across all chromosomes, and an overwhelming number of Polycomb-modified sites enriched with the trimethylated histone H3 on lysine 27 (H3K27me3) formed the main recruiting module for SYT-SSX2. PMID: 22594313
8. SS18-SSX1 and SS18-SSX2 variant translocations are associated with synovial sarcoma. PMID: 22976541
9. the initial events that likely occur when SYT-SSX2 is first expressed, and its dominant function in subverting the nuclear program of the stem cell, leading to its aberrant differentiation, as a first step toward transformation. PMID: 21996728
10. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes PMID: 22442726
11. the fusion gene SYT-SSX should be considered to play important role on Synovial sarcoma cell growth via ERK pathway PMID: 21234732
12. Rearranged SYT wasdetected in all synovial sarcomas but not in any Ewing sarcoma/primitive neuroectodermal tumors PMID: 20660338
13. The SYT protein has a unique QPGY domain, which is also present in the largest subunits, p250 and the newly identified homolog p250R, of the corresponding SNF/SWI complexes PMID: 11734557
14. coexistence of fusions with SSX1 and SSX2 in synovial sarcomas PMID: 12037676
15. SYT may function as a general coactivator PMID: 15919756
16. demonstrate differentially expressed genes for the 2 major gene fusion variants in SS, SS18/X breakpoint 1 sarcoma (SSX1) and SS18/SSX2, and thereby suggest that these result in different downstream effects PMID: 16152617
17. SYT interacts with SYT-interacting protein/co-activator activator PMID: 16227627
18. SYT-SSX2 contributes to tumor development, in part through beta-catenin signaling. PMID: 16462762
19. SS18 and SS18L1 genes map within co-linear DNA segments that may have evolved through a relatively recent genomic duplication event. PMID: 16484776
20. The SS18-SSX2 fusion protein may act as a so-called transcriptional "activator-repressor," which induces downstream target gene deregulation through epigenetic mechanisms. PMID: 17018603
21. SYT-SSX1 fusion protein directly down-regulated the expression of COM1, a regulator of cell proliferation. PMID: 17101797
22. endogenous LHX4 binds to the CGA promoter and that LHX4-mediated CGA activation is enhanced by the SS18-SSX protein PMID: 17667940
23. this sarcoma showed a longer-than-expected PCR product. Direct sequencing of the product disclosed a novel SYT/SSX1 fusion transcript. PMID: 17721327
24. SS18-SSX1 can negatively regulate p53 tumor-suppressive function by increasing the stability of its negative regulator HDM2. PMID: 18234968
25. Findings showing a complex cryptic rearrangement that gives rise to the characteristic SYT-SSX2 fusion gene in a monophasic synovial sarcoma patient. PMID: 18992642
26. SYT-SSX fusion type was not correlated with survival synovial sarcoma. PMID: 18997619
27. provides evidence that, in the appropriate context, expression of the SYT-SSX2 oncogene leads to loss of polycomb function PMID: 19337376
28. SYT-SSX1 is an adverse predictor for disease-specific survival and metastasis-free survival, but has no relation to local recurrence-free survival in synovial sarcoma. PMID: 19385976
29. findings indicate that cytoplasmic SYT isoforms interact with actin filaments and function in the ability cells to bind and react to specific extracellular matrices PMID: 19649286

Show More

Hide All

HGNC: 11340

OMIM: 600192

KEGG: hsa:6760

STRING: 9606.ENSP00000414516

UniGene: Hs.129261